Magnetic Nanoparticle Hyperthermia: Maximizing Specific Loss Power for Magnetic Hyperthermia by Hard-Soft Mixed Ferrites (Small 29/2018)

Nanoparticle Synthesis For Magnetic Hyperthermia

Intravenous magnetic nanoparticle cancer hyperthermia

Magnetic nanoparticles heated by an alternating magnetic field could be used to treat cancers, either alone or in combination with radiotherapy or chemotherapy. However, direct intratumoral injections suffer from tumor incongruence and invasiveness, typically leaving undertreated regions, which lead to cancer regrowth. Intravenous injection more faithfully loads tumors, but, so far, it has been...

Antitumor immunity by magnetic nanoparticle-mediated hyperthermia.

Magnetic nanoparticle-mediated hyperthermia (MNHT) generates heat to a local tumor tissue of above 43°C without damaging surrounding normal tissues. By applying MNHT, a significant amount of heat-shock proteins is expressed within and around the tumor tissues, inducing tumor-specific immune responses. In vivo experiments have indicated that MNHT can induce the regression of not only a local tum...

Magnetic nanoparticle hyperthermia for prostate cancer.

Magnetic nanoparticles are increasingly used for clinical applications such as drug delivery, magnetic resonance imaging and magnetic fluid hyperthermia. A novel method of interstitial heating of tumours following direct injection of magnetic nanoparticles has been evaluated in humans in recent clinical trials. In prostate cancer this approach has been investigated in two separate phase I studi...

Induced tissue cell death by magnetic nanoparticle hyperthermia for cancer treatment: an in silico study

In this paper, we simulate magnetic hyperthermia process on a mathematical phantom model representing cancer tumor and its surrounding healthy tissues. The temperature distribution throughout the phantom model is obtained by solving the bio-heat equations and the consequent cell death amount is calculated using correlations between the tissue local temperature and the cell death rate. To have a...